Contrarily to our study, none of these studies has investigated the role of this soluble molecule in a pan-cancer setting, including a range of different malignancies treated with different ICI agents or including comparisons with other drug classes such as chemotherapy and VEGF antibodies. Here, VEGFA is linked to cancer.